Try our Advanced Search for more refined results
Life Sciences - March, 2010
216 articles
- Pfizer Reveals $35M Payout To Docs, Hospitals In '09
- Allstate Owes Wyeth Defense For Ativan Suits: Judge
- Arthrex, DePuy Reach Accord On ACL Patent Suit
- Pfizer Not Excited About Teva's Generic Viagra
- Bayer Fails To Scrap Aspirin Marketing MDL
- Alphapharm Drops Antitrust Claims In Treximet IP Suit
- Fiduciary Duties In Delaware LLC Agreements
- Cephalon Off-Label Class Action Won't Be Reopened
- DNA — Not Patentable Subject Matter ...
- Astra Told To Pay Dr. Reddy's Fees In Prilosec Suit
- Gene Patent Ruling Could Shake Up Biotech
- Bayer Keeps Some Expert Opinions Out Of Trasylol MDL
- Plaintiff-Side Work For BigLaw Can Bring Profit, Pain
- Sandoz Seeks To Appeal Ruling In Effexor Spat
- Does Next Justice Work Across Street From Obama?
- Australian Creditors OK'd To Sue Over Lehman Losses
- J&J Unit Raided In Japanese Competition Probe
- Sidley Life Sciences Patent Pro Joins Quinn Emanuel
- Biosimilars Pathway: A Far Cry From Hatch-Waxman
- MDCO Sues Again For Extension Of Angiomax Patent
- Private Employers Push To Repeal Retiree Drug Tax
- Astellas Wins Look At OSI's Books Amid $3.5B Bid
- Antitrust Claims Survive In Cephalon Pay-To-Delay War
- Sandoz Antitrust Claims Nixed In Bayer's Yaz IP Suits
- Merck Deal, With $3.5M In Fees, OK'd Over Objections
- 7th Circ. Sends Bayer HIV Claims To Taiwan
- Workers Drop Doffing Claim In Bristol-Myers Suit
- Fed. Circ. Refuses To Nix Bayer's Animal Drug IP Suit
- AGA To Pay $35M To End Medtronic Stent Patent Suit
- Fed. Circ. Revives Enzo, Applera DNA Patent Case
- Judge Allows Baxter AWP Qui Tam Suit To Proceed
- Purchasers' Antitrust Suits Over Generic Plavix Tossed
- KV Pharmaceutical ERISA Class Action Tossed
- Plaintiffs' Lawyers Seek MDL For Pain Pump Suits
- Jury Hands $142M Win To Kaiser In Neurontin Battle
- Bayer Eludes Suit Over Multivitamin Marketing
- Frommer Lawrence, Fox Rothschild Add Darby Attys
- Mylan Antitrust Suit Over Mirapex Patent Sent To Del.
- EU Seeks Recall Of Acino Blood Thinner Clopidogrel
- The Written Description Requirement: It's Still Here
- Restitution Can Leave D&O Policyholders High And Dry
- Reverse Payment Suit Over Generic K-Dur Tossed
- Fed. Circ. Upholds Illumina Win In DNA Patent Spat
- Genzyme Says FDA Inspectors Will Oversee Plant
- Stryker Can't Escape Punitive Damages In Pump Suit
- Akin Gump Buys Democratic Lobby Boutique
- Transitions Optical — A Lens On Exclusive Dealing
- AstraZeneca OT Class Action Halted On Appeal
- Biogen Targets GSK's Cancer Drug Arzerra In IP Suit
- Stage-Setting For Circ Split: Generic Drug Preemption?
- Teva's $70M ARS Suit Against Deutsche Tossed
- Qui Tam Relator Barred From Suing Purdue: 4th Circ.
- Fed. Circ. Overturns $1.1M Pressure Products IP Win
- Medtronic Hit With Antitrust Suit Over Spine Treatments
- Axonyx Off Hook For Alzheimer's Drug Securities Suit
- AMRI, Sanofi Ask Judge To Block Generic Allegra
- Physician Payment Reporting Obligations: A Reality
- Walgreen To Cough Up $6M Over Wal-Born Claims
- Ariad Ruling Bolsters Written Description Requirement
- Morgan Lewis Reps Perrigo In $808M PBM Deal
- Alcon Lens Patent Suit Headed To Trial In One Piece
- Sanofi, Toshiba, Others Hit With False Marking Suits
- Ch. 11 Barred Nutrition Bar Maker's Bonuses: Trustee
- Jury Hands Covidien $4.8M In Surgical Device IP Case
- Patent Deemed Invalid In Edwards Heart Valve Suit
- Shire, Nostrum Strike Patent Deal Over Epilepsy Drug
- Obama Signs Health Care Bill As GOP Eyes Repeal
- Medical Experts Allowed In Pfizer Securities Suit
- FDA Suspends Use Of GSK's Rotavirus Vaccine
- Follow-On Biologics: Is Your Patent Portfolio Ready?
- Fed. Circ. Reaffirms Written Description Doctrine
- McWane To Pay Up To $12M For Ala. PCB Cleanup
- FDA Investigates Boston Scientific Defibrillator Recall
- Health Care Bill Heads To Obama's Desk
- Cell Therapeutics Sued Over 'False' New Drug Filings
- Guidant ERISA Plaintiffs Seek OK For $7M Settlement
- Supreme Court Won't Hear Tenn. Fen-Phen Case
- NJ Jury Finds For AstraZeneca In 1st Seroquel Verdict
- Alcon Shareholder Drops Bid To Block Novartis Deal
- Duane Reade Denies Owing Kasowitz Benson $7M Fee
- Norvir And The Difficulties In Analyzing Bundling
- Sanofi, Dabur Patent Dispute Over Eloxatin Survives
- Chantix MDL Plaintiffs Roll Out Master Complaint
- St. Jude Medical In Hot Water Over 'False' Financials
- Ex-Biovail Exec Can't Dodge SEC Fraud Suit
- International Trademark Filings Down 16%: WIPO
- Pristiq-Related ERISA Suit Against Wyeth Gets Booted
- Lilly Takes Aim At Synthon Over Adcirca ANDA
- Pay-For-Delay Ban Dropped From Health Care Bill
- Pfizer Drops Suit Against Lilly Over Viagra Patent
- Former King & Spalding Partner Forms IP Boutique
- Solvay Settles Estratest False Marketing Suit For $16M
- Medtronic ERISA Suit Over $510M IP Payouts Tossed
- Claims Pared In Dey, Sepracor IP Fight Over Brovana
- Kirkland Represents Teva In $5B Ratiopharm Deal
- Focusing On Food Labeling Enforcement
- Firm Pressures Drive More Partners In-House
- 2nd Circ. Seeks Input On Time Bars In Ephedra Case
- Top DOJ Health Fraud Cop Heads To Arnold & Porter
- Purdue To Settle OxyContin Antitrust MDL: Atty
- Tentative Deal Struck In Gilead Securities Action
- Fredrikson & Byron Reps Medtronic In $3B Debt Offering
- MDCO Gets 2nd Shot At Angiomax Patent Extension
- Asahi Kasei Ends Suit Over $91M Arbitration Award
- Mylan, Takeda Bury Hatchet In Diabetes Drug Feud
- Astellas Attempts To Oust OSI Board In Takeover Bid
- Cephalon Goes After Lupin In 6th Nuvigil Patent Suit
- Alpharma To Pay $42.5M Over Morphine Marketing
- Schering, Neutrogena Ads Are Both Misleading: Judge
- Inventor Tafas Seeks Fees In Suit Over USPTO Rules
- FTC Warning Letters: A New Era Of Enforcement?
- Trilipix ANDA Spurs Abbott, Fournier To Sue Impax
- On The Rise: Corporate Carveouts In The US
- Teleflex Issues IV Recall Over Possible Contamination
- KV Pharma Dodges WARN Act Class Action
- Boston Scientific Recalls 2 Types Of Defibrillator
- FDA Discovers Slew Of Quality Issues At Amylin Plant
- Cephalon Patent Suit Over Amrix Survives Dismissal
- FDA Slaps Black Box Warning On Plavix
- Pfizer Asserts 2nd Lyrica Patent Against Mylan
- Kaiser Asks To Admit 'Snake Oil' Barb In Neurontin Trial
- Fresenius Infringes Sanofi's Eloxatin Patent: Judge
- Sanofi To Pay $15M To Settle Sex Bias Class Action
- OSI Board Rejects Astellas $3.5B Bid
- Antitrust Enforcement Of Hospital Consolidations
- Fed. Claims Court Finds No Thimerosal-Autism Link
- Ranbaxy, Takeda Strike Licensing Deal Over Actos
- Shimadzu Resolves Caliper DNA Patent Suit
- CCS Medical's Ch. 11 Plan Approved
- IntelliPharmaCeutics, Elan Settle Focalin Patent Spat
- IP Boutique Darby & Darby To Close Down
- Medivation Sees Shareholder Ire Over Alzheimer's Drug
- Inyx USA Wins Reorganization Plan Approval
- Roxane Agrees To Hold Off On Generic Asacol
- Teen's Suit Against Teva Over Acne Drug Survives
- BMS, Novartis Sue Teva Over HIV Drug Reyataz
- Abbott Ordered To Turn Over E-Mail To Depakote Probe
- Corp. Counsel Warn Firms Not To Slack On Diversity
- Abbott Labs To Buy Facet Biotech For $450M
- Teva Sues Mylan Over Seasonique ANDA
- GlaxoSmithKline Infringes Antibody Patent: Genentech
- Wyeth, Biovail Deal Over Generic Effexor Wins OK
- Feds Probe Medtronic's Link To Mass. Clinic
- Sanofi Loses Injunction Bid In Generic Eloxatin Spat
- Wilson Sonsini Lures Back Cytokinetics GC
- Smith & Nephew Infringed Wound Treatment IP: Jury
- Allen & Overy Reps Novartis In $5B 3-Part Bond Issue
- Biovail Targets Paddock Over Aplenzin ANDA
- Calif. Appeals Court Backs MDA Preemption Clause
- Watson To License Takeda's Actos In Patent Deal
- Clarifying The Standard For Transfer In Eastern Texas
- GSK Tries To Axe Wellbutrin Consumer Antitrust Suit
- Supply Cos.' Antitrust Claims Against Hospitals Tossed
- GSK Tries To Halt Teva's Generic Combivir Launch
- Linklaters, Fried Frank Advise On Sanofi, Merck Deal
- Suggestions For Improving USPTO Re-Examinations
- Actavis Settles Mass. Medicaid Price Claims For $4M
- Watson's Opana ANDA Triggers Endo, Penwest Suit
- FDA Chief Walks Tightrope In 2011 Budget Talks
- National Union Says No To Forba Dental Scam Suit
- $1M Trimmed From $4.8M Award Over Remicade Ads
- Cost-Containment And The Need For Health Courts
- Sanofi-Aventis Units Look To Toss False Claims Suit
- Kinder Morgan, Ethanol Co. End Plant Explosion Feud
- Law360 Product Liability Editorial Advisory Board
- Graceway, 3M TRO Request In Nycomed Case Denied
- OxyContin Buyers Resolve Purdue Antitrust Claims
- Merck's Patent Tactics Violate Antitrust Law: Suit
- Supreme Court Narrows Scope Of Speedy Trial Act
- Celgene, Novartis Resolve ADHD Patent Suits
- 11th Circ. Upholds Dismissal Of Paxil Suicide Case
- Supreme Court To Tackle Vaccine Injury Preemption
- Atty Sanctions Sought In Merck-Schering Merger Suit
- AndroGel Buyer Seeks 2nd Shot At Pay-For-Delay Suit
- AstraZeneca Squashes Anasthetic Warning Suit
- DuPont, Others Pledge $30M To Promote Legal Diversity
- Cooper Cos. Fails To Shake Securities Class Action
- Jury To Decide Secrets Spat Between Doctor, Mayo
- Seattle IP Veteran Tellekson Leaps To Fenwick
- 'Intellact' Trademark Suit Survives Intel Dismissal Bid
- Australian Ruling Opens Door For 100s Of Vioxx Claims
- 9th Circ. Says No To Calif. Medicaid Cuts
- 40 Cases In Aredia, Zometa MDL Survive Dismissal Bid
- Willful Infringement Post-Seagate
- Evolving With Affirmative Defense Pleading Standard
- GAO Issues Scathing Review Of FDA Probe Oversight
- Nestle, Others Targeted By FDA Over Misleading Labels
- Pfizer Patent Adjustment Fight Remanded To USPTO
- 8th Circ. Upholds Another Dismissal In Baycol MDL
- Pfizer Spits Out Class Cert. In Listerine Ad Suit
- KV Unit Ethex To Pay $28M In Oversize Pill Case
- FDCA Precludes Wyeth Protonix Lanham Suit: Court
- Boehringer Seeks To Divide Claims In AWP Case
- AstraZeneca Escapes Liability In Pain Pump Suit
- Prilosec Food Poisoning Suit Gets The Boot
- Skadden Adds Patent Litigators From Dechert
- Boston Scientific Cross-Appeals Stent Patent Ruling
- Amgen ERISA Case Doesn't Hit Proper Targets: Judge
- $13.5M Award In Mead Formula Ad Spat Upheld
- Utah Court Tosses AG's AWP Suit
- DC Circ. Boosts Teva In Row With FDA Over Merck Drugs
- Sanofi Loses Last-Ditch Bid To Upend Eloxatin Deal
- Arnold & Porter Star Opts For Davis Polk, Not Retirement
- AstraZeneca Slaps Sun Pharma Over Nexium IV Generic
- Ortho, Braun Marked Drugs With Expired Patents: Suits
- Stryker Loses Bid To Toss Pain Pump Liability Suit
- Calif. County Sues GSK Over Alleged Avandia Risks
- Enzo Wins Interference Ruling In Siemens Patent Spat
- Nelson Levine Lures Another Cozen O'Connor Atty
- AstraZeneca To Pay Merck $647M For Drug Stake
- Astellas Ups Ante In $3.5B Hostile Bid For OSI
- Wyeth, Apotex Vie For Quick Win In Effexor Patent Suit
- CVS Hits KV With $100M Claim Over Recalled Drugs
- Merck To Buy Biotech Co. Millipore For $7.2B
- The Art Of Writing License Invitation Letters
- Baxter To Pay Up To $330M To Buy ApaTech